These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
588 related articles for article (PubMed ID: 20810285)
1. Structure-based virtual screening of novel tubulin inhibitors and their characterization as anti-mitotic agents. Kim ND; Park ES; Kim YH; Moon SK; Lee SS; Ahn SK; Yu DY; No KT; Kim KH Bioorg Med Chem; 2010 Oct; 18(19):7092-100. PubMed ID: 20810285 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of a series of podophyllotoxins derivatives as a class of potent antitubulin agents. Liu Y; Wei D; Zhao Y; Cheng W; Lu Y; Ma Y; Li X; Han C; Wei Y; Cao H; Zhao C Bioorg Med Chem; 2012 Nov; 20(21):6285-95. PubMed ID: 23022053 [TBL] [Abstract][Full Text] [Related]
3. Novel derivatives of 1,3,4-oxadiazoles are potent mitostatic agents featuring strong microtubule depolymerizing activity in the sea urchin embryo and cell culture assays. Kiselyov AS; Semenova MN; Chernyshova NB; Leitao A; Samet AV; Kislyi KA; Raihstat MM; Oprea T; Lemcke H; Lantow M; Weiss DG; Ikizalp NN; Kuznetsov SA; Semenov VV Eur J Med Chem; 2010 May; 45(5):1683-97. PubMed ID: 20110137 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of thiophene analogues of chalcones. Romagnoli R; Baraldi PG; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Sarkar T; Hamel E Bioorg Med Chem; 2008 May; 16(10):5367-76. PubMed ID: 18440234 [TBL] [Abstract][Full Text] [Related]
5. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors. Tahir SK; Han EK; Credo B; Jae HS; Pietenpol JA; Scatena CD; Wu-Wong JR; Frost D; Sham H; Rosenberg SH; Ng SC Cancer Res; 2001 Jul; 61(14):5480-5. PubMed ID: 11454695 [TBL] [Abstract][Full Text] [Related]
6. Quinolone analogue inhibits tubulin polymerization and induces apoptosis via Cdk1-involved signaling pathways. Chen YC; Lu PH; Pan SL; Teng CM; Kuo SC; Lin TP; Ho YF; Huang YC; Guh JH Biochem Pharmacol; 2007 Jun; 74(1):10-9. PubMed ID: 17475221 [TBL] [Abstract][Full Text] [Related]
7. 9-Benzylidene-naphtho[2,3-b]thiophen-4-ones as novel antimicrotubule agents-synthesis, antiproliferative activity, and inhibition of tubulin polymerization. Zuse A; Schmidt P; Baasner S; Böhm KJ; Müller K; Gerlach M; Günther EG; Unger E; Prinz H J Med Chem; 2006 Dec; 49(26):7816-25. PubMed ID: 17181164 [TBL] [Abstract][Full Text] [Related]
8. Novel tubulin-polymerization inhibitor derived from thalidomide directly induces apoptosis in human multiple myeloma cells: possible anti-myeloma mechanism of thalidomide. Iguchi T; Yachide-Noguchi T; Hashimoto Y; Nakazato S; Sagawa M; Ikeda Y; Kizaki M Int J Mol Med; 2008 Feb; 21(2):163-8. PubMed ID: 18204782 [TBL] [Abstract][Full Text] [Related]
9. BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo. Kuo CC; Hsieh HP; Pan WY; Chen CP; Liou JP; Lee SJ; Chang YL; Chen LT; Chen CT; Chang JY Cancer Res; 2004 Jul; 64(13):4621-8. PubMed ID: 15231674 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agents. Romagnoli R; Baraldi PG; Pavani MG; Tabrizi MA; Preti D; Fruttarolo F; Piccagli L; Jung MK; Hamel E; Borgatti M; Gambari R J Med Chem; 2006 Jun; 49(13):3906-15. PubMed ID: 16789746 [TBL] [Abstract][Full Text] [Related]
11. Discovery of novel 2-N-aryl-substituted benzenesulfonamidoacetamides: orally bioavailable tubulin polymerization inhibitors with marked antitumor activities. Liu Z; Zhou Z; Tian W; Fan X; Xue D; Yu L; Yu Q; Long YQ ChemMedChem; 2012 Apr; 7(4):680-93. PubMed ID: 22311585 [TBL] [Abstract][Full Text] [Related]
12. Design and biological evaluation of novel tubulin inhibitors as antimitotic agents using a pharmacophore binding model with tubulin. Kim DY; Kim KH; Kim ND; Lee KY; Han CK; Yoon JH; Moon SK; Lee SS; Seong BL J Med Chem; 2006 Sep; 49(19):5664-70. PubMed ID: 16970393 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of 2- and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization. Romagnoli R; Baraldi PG; Carrion MD; Lopez Cara C; Preti D; Fruttarolo F; Pavani MG; Tabrizi MA; Tolomeo M; Grimaudo S; Di Cristina A; Balzarini J; Hadfield JA; Brancale A; Hamel E J Med Chem; 2007 May; 50(9):2273-7. PubMed ID: 17419607 [TBL] [Abstract][Full Text] [Related]
14. Generation of ligand-based pharmacophore model and virtual screening for identification of novel tubulin inhibitors with potent anticancer activity. Chiang YK; Kuo CC; Wu YS; Chen CT; Coumar MS; Wu JS; Hsieh HP; Chang CY; Jseng HY; Wu MH; Leou JS; Song JS; Chang JY; Lyu PC; Chao YS; Wu SY J Med Chem; 2009 Jul; 52(14):4221-33. PubMed ID: 19507860 [TBL] [Abstract][Full Text] [Related]
15. 2-aroylindoles, a novel class of potent, orally active small molecule tubulin inhibitors. Beckers T; Reissmann T; Schmidt M; Burger AM; Fiebig HH; Vanhoefer U; Pongratz H; Hufsky H; Hockemeyer J; Frieser M; Mahboobi S Cancer Res; 2002 Jun; 62(11):3113-9. PubMed ID: 12036922 [TBL] [Abstract][Full Text] [Related]
16. Sulfonate derivatives of naphtho[2,3-b]thiophen-4(9H)-one and 9(10H)-anthracenone as highly active antimicrotubule agents. Synthesis, antiproliferative activity, and inhibition of tubulin polymerization. Zuse A; Schmidt P; Baasner S; Böhm KJ; Müller K; Gerlach M; Günther EG; Unger E; Prinz H J Med Chem; 2007 Nov; 50(24):6059-66. PubMed ID: 17973361 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents. Wang G; Li C; He L; Lei K; Wang F; Pu Y; Yang Z; Cao D; Ma L; Chen J; Sang Y; Liang X; Xiang M; Peng A; Wei Y; Chen L Bioorg Med Chem; 2014 Apr; 22(7):2060-79. PubMed ID: 24629450 [TBL] [Abstract][Full Text] [Related]
18. New C5-alkylated indolobenzazepinones acting as inhibitors of tubulin polymerization: cytotoxic and antitumor activities. Keller L; Beaumont S; Liu JM; Thoret S; Bignon JS; Wdzieczak-Bakala J; Dauban P; Dodd RH J Med Chem; 2008 Jun; 51(12):3414-21. PubMed ID: 18503262 [TBL] [Abstract][Full Text] [Related]
19. Cytotoxic activity and cytostatic mechanism of novel 2-arylbenzo[b]furans. Yang H; Pang JY; Cai YC; Xu ZL; Xian LJ J Pharm Pharmacol; 2006 Sep; 58(9):1281-7. PubMed ID: 16945188 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, biological evaluation, and molecular docking studies of 2,6-dinitro-4-(trifluoromethyl)phenoxysalicylaldoxime derivatives as novel antitubulin agents. Zhao TT; Lu X; Yang XH; Wang LM; Li X; Wang ZC; Gong HB; Zhu HL Bioorg Med Chem; 2012 May; 20(10):3233-41. PubMed ID: 22512906 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]